Gene · 4477
MSMB: microseminoprotein beta
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. MSMB: microseminoprotein beta. Genes, record 4477. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/4477
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P08118 | Beta-microseminoprotein | 114 | 2 | Ensembl, GeneID, HGNC |
Source UniProt
Patents53
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4650780 A2 | 2025-11-19 | 17477 | P08118 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 8990 | P08118 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 7084 | P08118 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 7084 | P08118 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 17477 | P08118 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 8990 | P08118 | Espacenet |
| KR 1020250010750 A | 2025-01-21 | 8990 | P08118 | Espacenet |
| JP 2024123008 A | 2024-09-10 | 6987 | P08118 | Espacenet |
| JP 2024109657 A | 2024-08-14 | 8997 | P08118 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 51320 | P08118 | Espacenet |
1 to 10 of 53
See all 53 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,170
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | MSMB papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 27 | 2025 |
| P50CA092629 | SPORE in Prostate Cancer | 23 | 2025 |
| P50CA097186 | The Pacific Northwest Prostate Cancer SPORE | 9 | 2025 |
| P30CA060553 | The Robert H. Lurie Comprehensive Cancer Center | 6 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 5 | 2025 |
| R01NS045585 | Role of microglial phagocytosis in prion diseases | 5 | 2025 |
| ZIACP010201 | Laboratory of Translational Genomics | 5 | 2025 |
| P30CA015704 | Cancer Center Support Grant | 4 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 4 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 4 | 2025 |
1 to 10 of 1,170Source NIH's project files
See all 1,170 nih grantsPapers2,399
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The phage shock protein A (PspA) maintains membrane potential and supports NADH dehydrogenase function in mycobacteria. | bioRxiv | 2026 | 42818691 | PubTator, text mining | PubMed |
| Discovery and validation of pumpkin seed protein-derived bioactive peptides targeting α-glucosidase: Insights into the molecular mechanisms. | Food Chem | 2026 | 42759368 | PubTator, text mining | PubMed |
| Current smoking and COPD are associated with differentiation-dependent secretory and inflammatory programs in airway basal cells. | Respir Res | 2026 | 42698073 | PubTator, text mining | PubMed |
| Developing a prognostic signature with cancer-associated fibroblasts for predicting the prognosis and immune landscape of prostate cancer. | Sci Rep | 2026 | 42697951 | PubTator, text mining | PubMed |
| The promise of deep urine proteomics for diagnosis of cancer, neurologic, and metabolic diseases. | PLoS One | 2026 | 42531325 | PubTator, text mining | PubMed |
Retraction notice to "Molecular structure and mechanism of protein MSMB, TPPP3, SPI1: Construction of novel 4 pancreatic cancer-related protein signatures model based on machine learning" [Int. J. Biol. Macromol. 307 (2025) 142075]. | Int J Biol Macromol | 2026 | 42527178 | PubTator, text mining | PubMed |
| PLCG2 signaling and genetic resilience in Alzheimer's disease. | Mol Neurodegener | 2026 | 41888907 | PubTator, text mining | PubMed |
| The oncogenic control of nucleotide synthesis. | Oncogenesis | 2026 | 41881963 | PubTator, text mining | PubMed |
| Integrative epigenomic landscape of Alzheimer's Disease brains reveals oligodendrocyte molecular perturbations associated with tau. | Nat Commun | 2026 | 41775686 | PubTator, text mining | PubMed |
| MicroRNA as Potential Biomarkers and Their Pathogenesis in Multiple System Atrophy. | Int J Mol Sci | 2026 | 41752011 | PubTator, text mining | PubMed |
1 to 10 of 2,399
See all 2,399 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/4477
GET https://conductscience.org/api/genes/v1/4477/patents?page=2